State AI Laws and Pharma Campaigns: Navigating One Brand Story Across a Patchwork U.S.

In 2026, the promise of artificial intelligence in pharma marketing is enormous. However, as brands deploy data‑driven media and AI‑powered...
A doctor using a tablet with a digital shield icon, representing real-time pharmacovigilance communication in pharmaceutical marketing.

Pharmacovigilance Marketing: Real-Time Safety Communication for Pharma Brands

Pharmacovigilance communication is rapidly becoming a core pillar of modern pharmaceutical marketing. As real-time safety monitoring shortens the gap between adverse event detection and...
A digital photograph of a medical desk with international flags, a checklist, and pharmaceutical tools symbolizing global pharma marketing and regulatory diversity.

Global Pharma Campaigns in a Fragmented Regulatory World

Global pharma marketing is undergoing a seismic shift. As data privacy laws tighten, drug pricing rules evolve, and artificial intelligence faces increasing scrutiny, pharmaceutical...
Strategic pharma launch plan on a clipboard surrounded by medication, stethoscope, and professionals in a meeting.

Launching a Drug in a Policy-Driven Market: How to Build a Risk-Ready Messaging Strategy

Bringing a drug to market has always been complex, but today’s launches face an entirely new layer of scrutiny. Accelerated approvals, pricing pressures, and...
Illustration of AI compliance in pharma marketing showing a robotic head, justice scale, compliance checklist, pills, and digital data integrations.

AI Compliance in Pharma Marketing: Building a Future-Proof Tech Stack

The pharmaceutical marketing world is embracing artificial intelligence (AI) faster than ever. But with innovation comes responsibility. AI systems used in pharma must not...
Pharmaceutical executive, doctor, and government official discussing drug pricing over money and medical tools, symbolizing pharma pricing communication

How Pharma Marketers Should Communicate Drug Price Negotiations

The role of pharma pricing communication has never been more critical. As governments and payers increasingly influence how drug prices are set and shared...
A healthcare professional in a lab coat shaking hands with a business executive, symbolizing a partnership between the pharmaceutical and non-pharma sectors surrounded by medical and technology icons.

Co-Branding with Caution: How Non-Pharma Partnerships Reshape Trust and Messaging

Pharma brand partnerships are transforming the way the pharmaceutical industry connects with consumers. As pharma brands increasingly collaborate with retailers, tech companies, and wellness...
disease awareness strategy, healthcare marketing, patient engagement, pharma communications, HCP engagement, digital health, omnichannel marketing, brand storytelling

From Awareness Days to Year-Round Action: Evolving Disease Campaigns for Lasting Impact

Each year, awareness days flood our social feeds with ribbons, hashtags, and heartfelt stories. Yet by the next month, the momentum often fades. This...
A healthcare professional and a digital startup leader shaking hands, symbolizing collaboration between pharma and digital health through data-driven technology and patient care innovation.

Competing for the Patient Relationship: What Pharma Can Learn from Digital Health Startups

As the healthcare industry embraces digital transformation, digital health partnerships are becoming essential to how patients experience care. Virtual care platforms, wearable technologies, and...
Hands holding a prescription bottle labeled "Accelerated Approval" surrounded by charts, pills, and lab documents representing conditional drug marketing strategies.

Marketing in the Gray Zone: Launching with Conditional Approvals and Incomplete Data

Accelerated and conditional drug approvals often bring early market access—but also evolving data and heightened regulatory sensitivity. This article explores how marketers can build...